VPHIF Financials: Valeo Pharma Inc AI Analysis



Financials

VPHIF Financial

Valeo Pharma Inc

As of today:Aug 06, 12:52:28 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$0.0001

Open

$0.1181

Day's Range

$0.0001 - $0.1181

52 week range

$0.0001 - $0.1181

Volume

4.5K

Avg.Volume

Dividend yield

EPS (TTM)

-0.27

Market Cap

$9.8K

What is VALEO PHARMA INC?

The company is headquartered in Kirkland, Quebec and currently employs 70 full-time employees.

Features

Markets

News

Breakdown	TTM	07/31/2024	04/30/2024	01/31/2024	10/31/2023	07/31/2023
Revenue	53	12	14	13	13	14
Revenue Growth (YoY)	0%	-14%	8%	0%	8%	133%
Cost of Revenue	44	9	11	11	12	9
Gross Profit	8	3	2	2	0	4
Selling, General & Admin	27	6	6	6	7	7
Research & Development	--	--	--	--	--	--
Operating Expenses	27	6	6	7	7	7
Other Non Operating Income (Expenses)	4	0	0	0	3	0
Pretax Income	-32	-8	-7	-6	-9	-5
Income Tax Expense	--	--	--	--	0	--
Net Income	-32	-8	-7	-6	-9	-5
Net Income Growth	14%	60%	17%	0%	-10%	25%
Shares Outstanding (Diluted)	98.67	98.67	98.67	86.13	93.15	84.47
Shares Change (YoY)	17%	17%	18%	6%	13%	3%
EPS (Diluted)	-0.34	-0.08	-0.07	-0.07	-0.09	-0.06
EPS Growth	-1%	20%	2%	3%	-19%	19%
Free Cash Flow	-9	0	-3	1	-7	-1
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	15.09%	25%	14.28%	15.38%	0%	28.57%
Operating Margin	-35.84%	-25%	-21.42%	-30.76%	-53.84%	-21.42%
Profit Margin	-60.37%	-66.66%	-50%	-46.15%	-69.23%	-35.71%
Free Cash Flow Margin	-16.98%	0%	-21.42%	7.69%	-53.84%	-7.14%
EBITDA	-17	-3	-3	-4	-7	-3
EBITDA Margin	-32.07%	-25%	-21.42%	-30.76%	-53.84%	-21.42%
D&A For EBITDA	2	0	0	0	0	0
EBIT	-19	-3	-3	-4	-7	-3
EBIT Margin	-35.84%	-25%	-21.42%	-30.76%	-53.84%	-21.42%
Effective Tax Rate	--	--	--	--	0%	--

Breakdown

TTM

07/31/2024

04/30/2024

01/31/2024

10/31/2023

07/31/2023

Revenue

Revenue Growth (YoY)

-14%

133%

Cost of Revenue

Gross Profit

Selling, General & Admin

Research & Development

Operating Expenses

Other Non Operating Income (Expenses)

Pretax Income

-32

-8

-7

-6

-9

-5

Income Tax Expense

Net Income

-32

-8

-7

-6

-9

-5

Net Income Growth

14%

60%

17%

-10%

25%

Shares Outstanding (Diluted)

98.67

86.13

93.15

84.47

Shares Change (YoY)

17%

18%

13%

EPS (Diluted)

-0.34

-0.08

-0.07

-0.09

-0.06

EPS Growth

-1%

20%

-19%

19%

Free Cash Flow

-9

-3

-7

-1

Free Cash Flow Per Share

Gross Margin

15.09%

25%

14.28%

15.38%

28.57%

Operating Margin

-35.84%

-25%

-21.42%

-30.76%

-53.84%

-21.42%

Profit Margin

-60.37%

-66.66%

-50%

-46.15%

-69.23%

-35.71%

Free Cash Flow Margin

-16.98%

-21.42%

7.69%

-53.84%

-7.14%

EBITDA

-17

-3

-4

-7

-3

EBITDA Margin

-32.07%

-25%

-21.42%

-30.76%

-53.84%

-21.42%

D&A For EBITDA

EBIT

-19

-3

-4

-7

-3

EBIT Margin

-35.84%

-25%

-21.42%

-30.76%

-53.84%

-21.42%

Effective Tax Rate

Follow-Up Questions

What are Valeo Pharma Inc's key financial statements?



According to the latest financial statement (Form-10K), Valeo Pharma Inc has a total asset of $0, Net loss of $0

What are the key financial ratios for VPHIF?



Valeo Pharma Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Valeo Pharma Inc's revenue broken down by segment or geography?



Valeo Pharma Inc largest revenue segment is North America, at a revenue of 3,166,116,000 in the most earnings release.For geography, Americas is the primary market for Valeo Pharma Inc, at a revenue of 3,200,924,000.

Is Valeo Pharma Inc profitable?



no, according to the latest financial statements, Valeo Pharma Inc has a net loss of $0

Does Valeo Pharma Inc have any liabilities?



no, Valeo Pharma Inc has liability of 0

How many outstanding shares for Valeo Pharma Inc?



Valeo Pharma Inc has a total outstanding shares of 0

Valeo Pharma Inc (VPHIF) Financial

VPHIF Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is VALEO PHARMA INC?

Valeo Pharma Inc (VPHIF) Financial

VPHIF Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is VALEO PHARMA INC?

VPHIF Income

Follow-Up Questions

What are Valeo Pharma Inc's key financial statements?

What are the key financial ratios for VPHIF?

How is Valeo Pharma Inc's revenue broken down by segment or geography?

Is Valeo Pharma Inc profitable?

Does Valeo Pharma Inc have any liabilities?

How many outstanding shares for Valeo Pharma Inc?